Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

Treating IBD Without TNFis and JAKs
Conference Coverage
07/24/2020
The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David Rubin, MD, offered his views at the...
The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David Rubin, MD, offered his views at the...
The treatment of inflammatory...
07/24/2020
Advances in Inflammatory Bowel Disease Network
Nutrition, Disease Localization Are Part of Preparing Patients With IBD for Surgery
Conference Coverage
07/02/2020
Some patients with IBD require surgery to improve symptoms and quality of life. Joel Goldberg, MD, explained how to help patients prepare for surgery and achieve optimum recovery at the Advances in Inflammatory Bowel Disease 2020 regional...
Some patients with IBD require surgery to improve symptoms and quality of life. Joel Goldberg, MD, explained how to help patients prepare for surgery and achieve optimum recovery at the Advances in Inflammatory Bowel Disease 2020 regional...
Some patients with IBD require...
07/02/2020
Advances in Inflammatory Bowel Disease Network
Positioning Therapies for IBD Requires Precision
Conference Coverage
06/27/2020
With increasing numbers of therapeutic agents to choose from, how do gastroenterologists make the best choice for initiating therapy and maintaining remission in their patients with IBD? David Rubin, MD, provided some guidance at the virtual...
With increasing numbers of therapeutic agents to choose from, how do gastroenterologists make the best choice for initiating therapy and maintaining remission in their patients with IBD? David Rubin, MD, provided some guidance at the virtual...
With increasing numbers of...
06/27/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Biosimilars Face High Expectations, But Also Barriers to Acceptance
Conference Coverage
06/27/2020
Should biosimilars be used as first-line or switch therapy for treating inflammatory bowel disease, and is it all about the costs? Alan Moss, MD, provided insights at the Advances in Inflammatory Bowel Disease 2020 regional meeting.
Should biosimilars be used as first-line or switch therapy for treating inflammatory bowel disease, and is it all about the costs? Alan Moss, MD, provided insights at the Advances in Inflammatory Bowel Disease 2020 regional meeting.
Should biosimilars be used as...
06/27/2020
Advances in Inflammatory Bowel Disease Network
Nutrition, Exercise Are Part of Preparing Patients With IBD for Surgery
Conference Coverage
06/26/2020
Some patients with IBD require surgery to improve symptoms and quality of life. Joel Goldberg, MD, explained how to help patients prepare for surgery and achieve optimum recovery at the Advances in Inflammatory Bowel Disease 2020 regional...
Some patients with IBD require surgery to improve symptoms and quality of life. Joel Goldberg, MD, explained how to help patients prepare for surgery and achieve optimum recovery at the Advances in Inflammatory Bowel Disease 2020 regional...
Some patients with IBD require...
06/26/2020
Advances in Inflammatory Bowel Disease Network
Conference Coverage
12/23/2019
Because patients with IBD are at an increased risk for venous thromboembolisms, authors of a new study presented at the 2019 AIBD Meeting sought to determine the rate of deep vein thrombosis prophylaxis in adults admitted for IBD flares.
Because patients with IBD are at an increased risk for venous thromboembolisms, authors of a new study presented at the 2019 AIBD Meeting sought to determine the rate of deep vein thrombosis prophylaxis in adults admitted for IBD flares.
Because patients with IBD are at...
12/23/2019
Advances in Inflammatory Bowel Disease Network

Advertisement

Conference Coverage
12/14/2019
Meenakshi Bewtra, MD, MPH, PhD, from the University of Pennsylvania, discussed medication failure as an important, but often forgotten, risk associated with 5-ASA in IBD, during a presentation at the 2019 AIBD Meeting.
Meenakshi Bewtra, MD, MPH, PhD, from the University of Pennsylvania, discussed medication failure as an important, but often forgotten, risk associated with 5-ASA in IBD, during a presentation at the 2019 AIBD Meeting.
Meenakshi Bewtra, MD, MPH, PhD,...
12/14/2019
Advances in Inflammatory Bowel Disease Network
News
12/13/2019
Sunanda Kane, MD, discussed key points from the AGA IBD in Pregnancy Clinical Care Pathway report during a presentation at the 2019 AIBD Meeting.
Sunanda Kane, MD, discussed key points from the AGA IBD in Pregnancy Clinical Care Pathway report during a presentation at the 2019 AIBD Meeting.
Sunanda Kane, MD, discussed key...
12/13/2019
Advances in Inflammatory Bowel Disease Network
Conference Coverage
12/12/2019
James Lewis, MD, explained how diet can influence the risk of developing Crohn disease and ulcerative colitis, as well as patient symptoms, during a presentation at the 2019 AIBD Meeting.
James Lewis, MD, explained how diet can influence the risk of developing Crohn disease and ulcerative colitis, as well as patient symptoms, during a presentation at the 2019 AIBD Meeting.
James Lewis, MD, explained how...
12/12/2019
Advances in Inflammatory Bowel Disease Network

Advertisement

Conference Coverage
12/12/2019
In a new study presented at the 2019 AIBD Meeting, researchers assessed the prevalence of anastomotic ring inflammation (ARI) in patients with Crohn disease who undergo ileal resection and ileocolonic anastomosis, as well as risk factors...
In a new study presented at the 2019 AIBD Meeting, researchers assessed the prevalence of anastomotic ring inflammation (ARI) in patients with Crohn disease who undergo ileal resection and ileocolonic anastomosis, as well as risk factors...
In a new study presented at the...
12/12/2019
Advances in Inflammatory Bowel Disease Network

Advertisement